Prev：Development of miRNA-based PROTACs targeting Lin28 for breast cancer therapy(A25022-12.5)
Next：Development of piperazine-and oxazine-linked pyrimidines as p65 subunit binders of NF–κB in human breast cancer cells(KTA2020-3.9)
